| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 275 |
| 1 | PREDNISONE | 19 |
| 2 | OMEPRAZOLE MAGNESIUM | 16 |
| 3 | ADALIMUMAB | 15 |
| 4 | CETIRIZINE HYDROCHLORIDE | 15 |
| 5 | ERGOCALCIFEROL | 15 |
| 6 | OMEPRAZOLE | 14 |
| 7 | LEVOTHYROXINE SODIUM | 10 |
| 8 | LORAZEPAM | 10 |
| 9 | ACETAMINOPHEN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REGENER-EYES | 1 | 0.0714 |
| 1 | POTASSIUM CITRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | 1 | 0.0385 |
| 2 | HALCINONIDE | 1 | 0.0052 |
| 3 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 2 | 0.0044 |
| 4 | PYRITHIONE ZINC | 2 | 0.0036 |
| 5 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0035 |
| 6 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 1 | 0.0032 |
| 7 | CYSTEAMINE HYDROCHLORIDE | 2 | 0.0030 |
| 8 | TETRACAINE | 1 | 0.0026 |
| 9 | CORTISOL | 1 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 275 |
| 1 | Corticosteroid [EPC] | 39 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 24 |
| 3 | Benzodiazepine [EPC] | 20 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 5 | Proton Pump Inhibitor [EPC] | 19 |
| 6 | Provitamin D2 Compound [EPC] | 15 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 14 |
| 8 | Atypical Antipsychotic [EPC] | 10 |
| 9 | Opioid Agonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 1 | 0.0057 |
| 1 | Ectoparasiticide [EPC] | 6 | 0.0024 |
| 2 | Interleukin-13 Antagonist [EPC] | 5 | 0.0007 |
| 3 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0007 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 275 | 0.0006 |
| 5 | Interferon alfa-2b [EPC] | 1 | 0.0006 |
| 6 | Carnitine Analog [EPC] | 2 | 0.0006 |
| 7 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0004 |
| 8 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 9 | Nonergot Dopamine Agonist [EPC] | 8 | 0.0003 |